Nuveen
OGN icon

Nuveen’s Organon & Co OGN Stock Holding History

Nuveen’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Buy
486,400
+17,469
+4% +$209K ﹤0.01% 1946
2026
Q1 		$2.81M Buy
468,931
+32,928
+8% +$248K ﹤0.01% 2140
2025
Q4 		$3.13M Sell
436,003
-124,502
-22% -$984K ﹤0.01% 2111
2025
Q3 		$5.99M Sell
560,505
-41,899
-7% -$411K ﹤0.01% 1820
2025
Q2 		$5.83M Buy
602,404
+13,218
+2% +$136K ﹤0.01% 1805
2025
Q1 		$8.77M Buy
589,186
+75,358
+15% +$1.16M ﹤0.01% 1626
2024
Q4 		$7.67M Sell
513,828
-20,356
-4% -$332K ﹤0.01% 1745
2024
Q3 		$10.2M Buy
534,184
+13,750
+3% +$285K ﹤0.01% 1589
2024
Q2 		$10.8M Sell
520,434
-54,772
-10% -$1.09M ﹤0.01% 1532
2024
Q1 		$10.8M Buy
575,206
+74,078
+15% +$1.27M ﹤0.01% 1541
2023
Q4 		$7.23M Sell
501,128
-84,650
-14% -$1.15M ﹤0.01% 1774
2023
Q3 		$10.2M Sell
585,778
-35,260
-6% -$735K ﹤0.01% 1473
2023
Q2 		$12.9M Sell
621,038
-58,853
-9% -$1.28M ﹤0.01% 1351
2023
Q1 		$16M Buy
679,891
+1,692
+0.2% +$45.4K 0.01% 1188
2022
Q4 		$18.9M Sell
678,199
-28,794
-4% -$736K 0.01% 1076
2022
Q3 		$16.5M Buy
706,993
+16,077
+2% +$485K 0.01% 1143
2022
Q2 		$23.3M Sell
690,916
-3,963
-0.6% -$139K 0.01% 947
2022
Q1 		$24.2M Sell
694,879
-15,967
-2% -$546K 0.01% 1070
2021
Q4 		$21.6M Sell
710,846
-52,375
-7% -$1.71M 0.01% 1181
2021
Q3 		$25M Buy
763,221
+137,843
+22% +$4.41M 0.01% 1114
2021
Q2 		$18.9M Buy
+625,378
New +$20.6M 0.01% 1410

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Nuveen's OGN Position: Q2 2026 in Review

Nuveen increased its Organon & Co (OGN) stake by 3.7% in Q2 2026, buying an estimated $209K and bringing the position to 486,400 shares worth $6.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1946.

Nuveen first reported a position in OGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $25M in Q3 2021. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Nuveen held 486,400 shares of Organon & Co worth $6.59M as of Q2 2026.
  • Nuveen bought 17,469 Organon & Co shares in Q2 2026, an estimated $209K.
  • Organon & Co made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1946 holding.
  • Nuveen first reported a position in Organon & Co in Q2 2021 and has held it in 21 quarters since.
  • Nuveen's Organon & Co position peaked at $25M in Q3 2021.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.